Religare, the investment gateway of India

#1
Religare, a Ranbaxy promoter group company, a leading integrated financial services institution of India is coming out with its maiden public offer soon.

About RANBAXY: Ranbaxy Laboratories Limited, headquartered in India, is an integrated; research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. The Company is ranked amongst the top ten global generic companies and has a presence in 23 of the top 25 pharma markets of the world. The Company with a global footprint in 49 countries, world class manufacturing facilities in 11 and a diverse product portfolio, is rapidly moving towards global leadership, riding on its success in the worlds emerging and developed markets.

About Religare: Religare offers a large and diverse bouquet of services ranging from equities, commodities, insurance broking, to wealth advisory, portfolio management services, personal finance services, Investment banking and institutional broking services.

Religares retail network spreads across the length and breadth of the country with its presence through more than 1,217 locations across more than 392 cities and towns. Having spread itself fairly well across the country it has also aggressively started eyeing global geographies.

And now some latest news from this business house.

1) AEGON Religare Life Insurance - Life Insurance Company, a Joint Venture with Aegon

Religare AEGON AMC - Asset Management Company, a Joint Venture with Aegon

The Ranbaxy group made an ambitious expansion in its financial sector business by foraying into life insurance and asset management businesses. The groups financial arm, Religare joined hands with the Dutch financial group Aegon for forming two separate joint ventures for these businesses.
The Religare-Aegon combine also plans to get into healthcare insurance as and when the government comes out with new guidelines for investments in this segment. Currently, non-life insurance companies can operate in the healthcare insurance segment as well, while life insurance companies can provide only rider policies.

2) Australia's Sydney-based Macquarie Bank has entered into a 50:50 joint venture with Religare Enterprises for wealth management.
Religare Macquarie Wealth Ltd, in which the two firms will hold equal stakes, will focus on the growing base of wealthy Indians, which expanded at nearly 21 percent in 2006, a recent study by Merrill Lynch and Cap Gemini showed.
The new outfit, Religare Macquarie Wealth Limited, will start operations in two months with products for high net worth individuals in India and non-resident Indians in Australia. Macquarie has a presence in 24 countries.

3) Merrill Lynch, one of the world's leading wealth management, capital markets and advisory companies, has bought 5% stake for Rs 61-62 crore in the Religare ahead of the company's initial public offering. The stake has been picked up by Indopark Holdings, a wholly owned subsidiary of Merrill Lynch & Co Inc.
This values Religare, the financial services company owned by the promoters of Ranbaxy laboratories, at Rs, 1,220 crore to 1250 crore.


Open - 29 Oct
Close - 01 Nov
Issue Type -100% Book Building Issue
Issue Size - 7,576102 Equity Shares Of Rs. 10 Each
Issue Price - Rs 160/- to Rs 185/- Per Equity Share
Maximum Subscription Amount for Retail Investor: Rs 100,000/-
Listing - BSE, NSE
Lead Manager- Enam Financial Consultants Private Limited & Citigroup Global Markets India Private Limited
 

koolfriend4u

Well-Known Member
#2
Religare Enterprises has fixed the issue price of its initial public offering (IPO) at Rs 185 per share.

The company had come out with an IPO of 75,76,102 equity shares of Rs 10 each in a price band of Rs 160 and Rs 185 per share. The issue opened on October 29, 2007, and closed on November 1, 2007.

The issue was subscribed approximately around 161 times. Religare is promoted by the promoters of Ranbaxy Laboratories.

source: http://www.business-standard.com

:) Happy trading ...

Retail traders subscried more than 90% i read. Good luck to all those subscribed

Happy trading

-koolfriend4u
 

koolfriend4u

Well-Known Member
#3
Religare Enterprises has fixed the issue price of its initial public offering (IPO) at Rs 185 per share.

The company had come out with an IPO of 75,76,102 equity shares of Rs 10 each in a price band of Rs 160 and Rs 185 per share. The issue opened on October 29, 2007, and closed on November 1, 2007.

The issue was subscribed approximately around 161 times. Religare is promoted by the promoters of Ranbaxy Laboratories.

source: www.business-standard

:) Happy trading ...

Retail traders subscried more than 90times, i read. Good luck to all those subscribed

Happy trading

-koolfriend4u
 

Similar threads